Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

NCT04872621

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Research Site Aichi, Japan

Research Site Aichi, Japan

Research Site Akita, Japan

Research Site Aomori, Japan

View all 59 locations

View Trial Details

Completed

A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization

NCT06547112

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

NCT02136134

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Birmingham, Alabama, United States

Los Angeles, California, United States

Stamford, Connecticut, United States

Jacksonville, Florida, United States

View all 105 locations

View Trial Details

Completed

Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial

NCT00911183

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Institut Bergonie Bordeaux, France

View Trial Details

Completed

Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events

NCT05123001

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Completed

Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides

NCT03695471

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +21 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Completed

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

Conditions: Advanced Solid Tumor, Blood Protein Disorders, Bronchial Neoplasms, +62 more
Locations: UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States

Mayo Clinic Jacksonville - PPDS Jacksonville, Florida, United States

Goshen Health System Goshen, Indiana, United States

Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View all 22 locations

View Trial Details

Completed

Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00278408

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +21 more
Locations: Rigshospitalet, Department of Hematology Copenhagen, Denmark

Amtssygehuset i Herlev Herlev, Denmark

GMP Tummes/Weinberg Aachen, Germany

Klinikum St. Marien Amberg, Germany

View all 152 locations

View Trial Details

Completed

CD19 CAR T-Cell Therapy for R/R Non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia

NCT06027957

Conditions: B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Burkitt Lymphoma, +16 more
Locations: Vinmec Research Institute of Stem Cell and Gene Technology Hanoi, Vietnam

View Trial Details

Completed

Enhanced Assistance During Radiotherapy for Unmet Essential Needs

NCT06582849

Conditions: Adnexal Diseases, Anal Cancer, Anus Diseases, +117 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions